Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse M Cedarbaum

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2018
Elephants, Parkinson's Disease, and Proof-of-Concept Clinical TrialsJesse M Cedarbaum
Movement Disorders : Official Journal of the Movement Disorder Society|April 29, 2018
Targeted Therapies for Parkinson's Disease: From Genetics to the ClinicS Pablo Sardi, Jesse M Cedarbaum, Patrik Brundin
Annals of Neurology|May 26, 2017
Fletcher H. McDowell, MD, 1923-2017Jesse M Cedarbaum, Mindy Aisen, Bruce T Volpe
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 24, 2012
Mild cognitive impairment: disparity of incidence and prevalence estimatesAlex Ward, H Michael Arrighi, Shannon Michels, et al.
Journal of Parkinson'S Disease|April 25, 2022
Tracking Emergence of New Motor and Non-Motor Symptoms Using the MDS-UPDRS: A Novel Outcome Measure for Early Parkinson's Disease?Michelle H S Tosin, Tanya Simuni, Glenn T Stebbins, et al.
Parkinsonism & Related Disorders|October 1, 2024
Validating new symptom emergence as a patient-centric outcome measure for PD clinical trialsHaotian Zou, Glenn T Stebbins, Tanya Simuni, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 5, 2012
Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trialsJesse M Cedarbaum, Mark Jaros, Chito Hernandez, et al.
Parkinsonism & Related Disorders|August 20, 2021
Quantitative digital clock drawing test as a sensitive tool to detect subtle cognitive impairments in early stage Parkinson's diseaseTamara Schejter-Margalit, Rachel Kizony, Julia Shirvan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 17, 2015
Item response theory analysis of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised in the Pooled Resource Open-Access ALS Clinical Trials DatabaseElizabeth D Bacci, Dorota Staniewska, Karin S Coyne, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 4, 2022
A qualitative evaluation of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R) by the patient community: a web-based cross-sectional surveyDanielle Boyce, Michael Robinson, Jesse M Cedarbaum, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2018
Elephants, Parkinson's Disease, and Proof-of-Concept Clinical TrialsJesse M Cedarbaum
Movement Disorders : Official Journal of the Movement Disorder Society|April 29, 2018
Targeted Therapies for Parkinson's Disease: From Genetics to the ClinicS Pablo Sardi, Jesse M Cedarbaum, Patrik Brundin
Annals of Neurology|May 26, 2017
Fletcher H. McDowell, MD, 1923-2017Jesse M Cedarbaum, Mindy Aisen, Bruce T Volpe
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 24, 2012
Mild cognitive impairment: disparity of incidence and prevalence estimatesAlex Ward, H Michael Arrighi, Shannon Michels, et al.
Journal of Parkinson'S Disease|April 25, 2022
Tracking Emergence of New Motor and Non-Motor Symptoms Using the MDS-UPDRS: A Novel Outcome Measure for Early Parkinson's Disease?Michelle H S Tosin, Tanya Simuni, Glenn T Stebbins, et al.
Parkinsonism & Related Disorders|October 1, 2024
Validating new symptom emergence as a patient-centric outcome measure for PD clinical trialsHaotian Zou, Glenn T Stebbins, Tanya Simuni, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 5, 2012
Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trialsJesse M Cedarbaum, Mark Jaros, Chito Hernandez, et al.
Parkinsonism & Related Disorders|August 20, 2021
Quantitative digital clock drawing test as a sensitive tool to detect subtle cognitive impairments in early stage Parkinson's diseaseTamara Schejter-Margalit, Rachel Kizony, Julia Shirvan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 17, 2015
Item response theory analysis of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised in the Pooled Resource Open-Access ALS Clinical Trials DatabaseElizabeth D Bacci, Dorota Staniewska, Karin S Coyne, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 4, 2022
A qualitative evaluation of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R) by the patient community: a web-based cross-sectional surveyDanielle Boyce, Michael Robinson, Jesse M Cedarbaum, et al.
Pageof 8